Aleph Farms has obtained permission to market its thin-cut cultivated beef steaks in Singapore and intends to introduce them during the first half of 2027, chief executive Didier Toubia told AgFunderNews. The company expects to begin with selected restaurants.
Commercial sales will depend on Cell Agritech producing market-ready batches at its Singapore operation, according to Toubia. He said that site would handle the opening production run, while Cell Agritech’s larger Penang plant could provide additional volume if demand increases.
Aleph Farms has also simplified its manufacturing method by partially developing cells into muscle and fat within the initial bioreactor before combining them with a plant-protein matrix, Toubia told AgFunderNews. Chief technology officer Neta Lavon said a company-commissioned independent techno-economic analysis used 5,000-liter bioreactors and calculated a 47% gross margin at conventional-beef price parity, production costs of $6.45 per pound and a 2.5-year payback period.
Several commercial details remain unsettled. Toubia said potential Singapore foodservice partners have not been disclosed, while technology transfer at Cell Agritech and Switzerland’s The Cultured Hub is expected to produce operational lines during 2027. He also confirmed layoffs connected to Aleph Farms’ move from pilot production in Israel toward outside manufacturers. Although the company received Israeli sales clearance in 2023, Toubia said Singapore and Switzerland are being prioritized. AgFunderNews did not identify the Singapore regulator or detail the authorization’s conditions.
CONCLUSION The clearance moves Aleph Farms closer to restaurant sales, but launch timing still depends on commercial manufacturing in Singapore. The next milestones are operational partner facilities, named foodservice customers and further regulatory progress in the company’s priority markets.